Crossmark

Inhibition of myocyte-specific enhancer factor 2A (MEF2A) attenuates cardiac fibrosis and improves heart function by regulating the Snail1/RhoA/α-SMA pathway

Crossref DOI link: https://doi.org/10.1007/s10863-025-10075-w

Published Online: 2025-09-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jiang, Qianzhu

Li, Huiting
Funding

Funding for this research was provided by:

This work was supported by the Heilongjiang Province Traditional Chinese Medicine Research Project (ZHY2023-170, ZHY2023-170)
License Information

Text and Data Mining valid from 2025-09-01

Version of Record valid from 2025-09-01
More Information

Article History

Received: 8 May 2025

Accepted: 18 August 2025

First Online: 1 September 2025

Declarations

:

: The authors declare no competing interests.

: All the animal protocols were reviewed and approved by the Commission’s institutional laboratory (CIL-[AP]-022.25).

Document is current

Any future updates will be listed below